Titan Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
TTNP Titan Pharmaceuticals Inc
ACMR ACM Research Inc
SDY SPDR® S&P Dividend ETF
DIS Walt Disney Co
AAPL Apple Inc
MLM Martin Marietta Materials Inc
GOOG Alphabet Inc
FCNTX Fidelity® Contrafund® Fund
MSFT Microsoft Corp
GLPG Galapagos NV
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's ProNeura continuous drug delivery system consists of a small, solid rod made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The Company focuses on developing two product development programs, the first one with a ropinirole implant for the treatment of Parkinson's disease (PD) and the second one with a Triiodothyronine (T3) implant for the treatment of hypothyroidism.

Price
Delayed
$2.31
Day's Change
0.07 (3.12%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.40
Day's Low
2.28
Volume
(Below Average)

Today's volume of 64,984 shares is on pace to be lower than TTNP's 10-day average volume of 187,106 shares.

64,984
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

The risk of loss in trading futures can be substantial. Clients must consider all relevant risk factors, including their own personal financial situation, before trading. Margin and level 2 options approval or higher is required. Not all account owners will qualify.

Dividends are converted to USD using the current rate of exchange at the end of the business day on the day the dividend went EX. Earnings are converted to USD using the current rate of exchange at the end of the business day on the day earnings were announced.

Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.